Cases & Deals

  • Home
  • Practices
  • Abbott acquires Visiogen in a $400 million private company merger

Share

Abbott acquires Visiogen in a $400 million private company merger

October 2009

Client(s) Abbott Laboratories

Jones Day advised Abbott Laboratories in the $400 million acquisition of Visiogen, Inc., an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts.

In addition to M&A representation, Jones Day provided antitrust, benefits, healthcare, and IP advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.